Zentalis Pharmaceuticals (ZNTL) has released an update to notify the public and investors about a regulation fd disclosure.
On January 25, 2024, Zentalis publicly released a press statement, which, although incorporated by reference in a Current Report, is not considered legally “filed” under Section 18 of the Securities Exchange Act of 1934. Consequently, it does not carry the associated liabilities and is not automatically included in any future securities filings unless specifically referenced.
For further insights into ZNTL stock, check out TipRanks’ Stock Analysis page.